CD10 expression by melanoma cells is associated with aggressive behavior in vitro and predicts rapid metastatic progression in humans

Journal of Dermatological Science

Volumn 69, Issue 2, 2013, Pages 105-113

  Thomas Pfaab, Marianne ^a   Annereau, Jean Philippe ^b   Munsch, Coline ^a   Guilbaud, Nicolas ^b   Garrido, Ignacio ^a   Paul, Carle ^a   Brousset, Pierre ^a   Lamant, Laurence ^a   Meyer, Nicolas ^a  

^a Centre de Recherche et Développement Pierre Fabre ^*  (France)

^b Centre d'Immunologie Pierre Fabre   (France)

Author keywords

Biomarker; CD10; CD133; Melanoma; Nestin

Indexed keywords

CD133 ANTIGEN; CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; MESSENGER RNA; NESTIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; MALE; MELANOMA CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN METASTASIS; TUMOR XENOGRAFT;

EID: 84873567604     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.11.003     Document Type: Article

References (26)

1. Balch C.M., Gershenwald J.E., Soong S.-J., Thompson J.F., Atkins M.B., Byrd D.R., et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
2. Bertucci F., Pages C., Finetti P., Rochaix P., Lamant L., Devilard E., et al. Gene expression profiling of human melanoma cell lines with distinct metastatic potential identifies new progression markers. Anticancer Res 2007, 27:3441-3449.
3. Velazquez E.F., Yancovitz M., Pavlick A., Berman R., Shapiro R., Bogunovic D., et al. Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma. J Transl Med 2007, 5:2.
4. Oba J., Nakahara T., Hayashida S., Kido M., Xie L., Takahara M., et al. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. J Am Acad Dermatol 2011, 65:1152-1160.
5. Roques B.P., Noble F., Daugé V., Fournié-Zaluski M.C., Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 1993, 45:87-146.
6. Maguer-Satta V., Besançon R., Bachelard-Cascales E. Concise review: neutral endopeptidase (CD10): a multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells 2011, 29:389-396.
7. Lerwill M.F. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004, 28:107-1091.
8. Hu M., Yao J., Carroll D.K., Weremowicz S., Chen H., Carrasco D., et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell 2008, 13:394-406.
9. Ishiwata T., Matsuda Y., Naito Z. Nestin in gastrointestinal and other cancers: effects on cell and tumor angiogenesis. World J Gastroenterol 2011, 17:409-418.
10. Tanabe K., Amoh Y., Kanoh M., Takasu H., Sakai N., Sato Y., et al. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma. Eur J Dermatol 2010, 20:283-288.
11. Fusi A., Ochsenreither S., Busse A., Rietz A., Keilholz U. Expression of the stem cell marker nestin in peripheral blood of patients with melanoma. Br J Dermatol 2010, 163:107-114.
12. Fusi A., Reichelt U., Busse A., Ochsenreither S., Rietz A., Maisel M., et al. Expression of the stem cell markers nestin and CD133 on circulating melanoma cells. J Invest Dermatol 2011, 131:487-494.
13. Zabierowski S.E., Herlyn M. Melanoma stem cells: the dark seed of melanoma. J Clin Oncol 2008, 26:2890-2894.
14. Schatton T., Frank M.H. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 2008, 21:39-55.
15. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65:9328-9337.
16. Thomas C.P., Buronfosse A., Portoukalian J., Fertil B. Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo. Cancer Lett 1995, 88:221-225.
17. Balch C.M., Gershenwald J.E., Soong S.-J., Thompson J.F., Ding S., Byrd D.R., et al. Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 2010, 28:2452-2459.
18. Clark E.A., Golub T.R., Lander E.S., Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000, 406:532-535.
19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
20. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
21. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002, 3. [RESEARCH0034].
22. Andersen C.L., Jensen J.L., Ørntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5245-5250.
23. Bilalovic N., Sandstad B., Golouh R., Nesland J.M., Selak I., Torlakovic E.E. CD10 protein expression in tumor and stromal cells of malignant melanoma is associated with tumor progression. Mod Pathol 2004, 17:1251-1258.
24. Iwaya K., Ogawa H., Izumi M., Kuroda M., Mukai K. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch 2011, 17:409-418.
25. Ogawa H., Iwaya K., Izumi M., Kuroda M., Serizawa H., Koyanagi Y., et al. Expression of CD10 by stromal cells during colorectal tumor development. Hum Pathol 2002, 33:806-811.
26. Kanoh M., Amoh Y., Tanabe K., Maejima H., Takasu H., Katsuoka K. Nestin is expressed in HMB-45 negative melanoma cells in dermal parts of nodular melanoma. J Dermatol 2010, 37:505-511.